Welcome to the UPF Digital Repository

Cost-effectiveness and cost-utility study of hypercholesterolemia treatment in Spain: evolocumab added to standard of care vs standard of care.



Cost-effectiveness and cost-utility study of hypercholesterolemia treatment in Spain: evolocumab added to standard of care vs standard of care.

Thumbnail
Document Type: Master Thesis
Date: 2022
Thumbnail

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking